LEXINGTON, Mass., Oct. 3, 2025 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that on October 1, 2025, the […]
FRANKLIN, Tenn., Oct. 3, 2025 /PRNewswire/ — Community Healthcare Trust Incorporated (NYSE: CHCT) today announced that on Tuesday evening, October 28, 2025, after the market closes, it will report results for the third quarter of […]
Celebrating compassion, sustainability and global care for animals BOULDER, Colo., Oct. 4, 2025 /PRNewswire/ — In recognition of World Animal Day, Project AnimalAid, a Boulder-based 501(c)(3) nonprofit, is reaffirming its mission to improve animal health and […]
AUSTIN, Texas, Oct. 3, 2025 /PRNewswire/ — eHealth, Inc. (Nasdaq: EHTH) (ehealth.com), a leading private online health insurance marketplace (the “Company”), today announced that on October 1, 2025, the Compensation Committee of its Board of Directors granted an […]
PHILADELPHIA, Oct. 3, 2025 /PRNewswire/ — LEGAL NOTICE If You Paid or Reimbursed for Certain PRESCRIPTION GENERIC DRUGS in the United States between May 1, 2009 and December 31, 2019, You Could Get a Payment […]
